Catalyst Biosciences, Inc. (CBIO): Price and Financial Metrics

Catalyst Biosciences, Inc. (CBIO)

Today's Latest Price: $5.99 USD

0.13 (2.22%)

Updated Jul 10 4:00pm

Add CBIO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

CBIO Daily Price Range
CBIO 52-Week Price Range

CBIO Stock Price Chart Technical Analysis Charts

CBIO Price/Volume Stats

Current price $5.99 52-week high $8.94
Prev. close $5.86 52-week low $3.43
Day low $5.72 Volume 287,806
Day high $6.12 Avg. volume 302,398
50-day MA $6.72 Dividend yield N/A
200-day MA $5.97 Market Cap 72.34M

Catalyst Biosciences, Inc. (CBIO) Company Bio

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. The company is based in South San Francisco, California.

CBIO Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CBIO Latest Social Stream

Loading social stream, please wait...

View Full CBIO Social Stream

Latest CBIO News From Around the Web

Below are the latest news stories about Catalyst Biosciences Inc that investors may wish to consider to help them evaluate CBIO as an investment opportunity.

Does Catalyst Biosciences' (NASDAQ:CBIO) Share Price Gain of 34% Match Its Business Performance?

It might be of some concern to shareholders to see the Catalyst Biosciences, Inc. (NASDAQ:CBIO) share price down 24...

Yahoo | July 9, 2020

Hedge Funds Still Very Bullish On Catalyst Biosciences Inc (CBIO)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | July 8, 2020

Catalyst Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The stock option was granted as an inducement material to Mr. Musil’s entering into employment with Catalyst in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option was granted outside of Catalyst’s 2018 Omnibus Incentive Plan, but except as set forth in the stock option agreement, will generally be subject to the same terms and conditions as apply to stock options granted under the plan.

Yahoo | July 1, 2020

Catalyst Biosciences joins Russell 2000 index

Catalyst Biosciences ([[CBIO]] +3.6%) has been added to the Russell 2000 Index, effective today. Press release...

Seeking Alpha | June 29, 2020

Catalyst Biosciences Added to Russell 2000 Index

SOUTH SAN FRANCISCO, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), today announced that it has been added to the…

GlobeNewswire | June 29, 2020

Read More 'CBIO' Stories Here

CBIO Price Returns

1-mo -19.81%
3-mo 18.61%
6-mo -13.06%
1-year -29.53%
3-year 36.14%
5-year -97.18%
YTD -12.04%
2019 -13.69%
2018 -42.16%
2017 39.90%
2016 -79.23%
2015 -77.10%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7959 seconds.